The news story you are looking for has expired. A more recent related article is displayed below.

Ads by Google

Repros Therapeutics to raise $1 million in financing

Sep 09, 2009 (Datamonitor via COMTEX) --

Company: Repros Therapeutics Inc (RPRX)

Repros Therapeutics, a developer of oral small molecule drugs, has entered into a definitive agreement with a single institutional investor to sell 1.5 million shares of its common stock at $0.65 per share for gross proceeds of approximately $1 million.

This financing will allow Repros to continue its business activity for the near term and provide it with more flexibility to continue exploring various strategic alternatives.

The offering is expected to close on or about September 11, 2009, subject to the satisfaction of customary closing conditions. 

http://www.datamonitor.com

Republication or redistribution, including by framing or similar means,
is expressly prohibited without prior written consent. Datamonitor shall 
not be liable for errors or delays in the content, or for any actions 
taken in reliance thereon

Copyright (C) 2009 Datamonitor. All rights reserved

News Provided by COMTEX

Company: Repros Therapeutics Inc (RPRX)


Related terms: business, drugs

Related Articles

A Three-Way Strategy on Repros Therapeutics
Oct 26, 2009
...activity surged in Repros Therapeutics (RPRX) on Friday...Way Strategy on Repros Therapeutics Oct 26, 2009 ...Biotech as Public Financing Takes a Breather...Way Strategy on Repros Therapeutics Oct 26, 2009...

Havertys declares one-time dividend on stock
Nov 11, 2009
...time cash payment on two classes of its common stock due to recent business improvements...dividend of 2.25 cents per share on its common stock and 2 cents per share on Class A common stock, payable Dec. 11 to shareholders of...

Repros Therapeutics settles with major creditors
Oct 30, 2009
...Repros chairman Repros Therapeutics in critical condition...Biopharmaceutical company Repros Therapeutics Inc. on Friday...pursue additional financing and strategic options...Find Executives Repros Therapeutics Inc. SITE SECTIONS...

Repros Therapeutics Inc. Reports Third Quarter 2009 Financial Results - Zibb.com
Nov 9, 2009
...shares of common stock outstanding...shares of our common stock at a purchase...shares of our common stock, at $1...potential new financing alternatives... About Repros Therapeutics Repros...oral small molecule drugs for major...